Alterity Therapeutics Limited (ATHE)
NASDAQ·Healthcare·Biotechnology
$2.43
+9.46%
Mkt Cap $32.18M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$8.00
Range $2.00 – $12.00
Implied Upside
+229.2%
Consensus $8.00 vs current $2.43
NASDAQ·Healthcare·Biotechnology
$2.43
+9.46%
Mkt Cap $32.18M
No recent rating data.
Price Target (4 analysts)
$8.00
Range $2.00 – $12.00
+229.2%
Consensus $8.00 vs current $2.43